EPISODE · May 10, 2021 · 16 MIN

A Critical Platform

from New Matter: Inside the Minds of SLAS Scientists · host SLAS

Join Ross Lagoy and Marshall discussing CRISPR/Cas9 genome editing, developing critical platform technologies that accelerate drug discovery and how to connect the bench to automation. Ross is a Senior Scientist at Intellia Therapeutics working to establishing new technologies and analysis pipelines to help identify potential cures for patients living with genetic disease.Upcoming Events:SLAS Meet-UpsLeiden, Netherlands (10 September 2026)Tübingen, Germany (20 October 2026)SLAS 2026 Sample Management Symposium (October 21-22, 2026 | South San Francisco, California)SLAS2027 International Conference & Exhibition (January 30 - February 3, 2027 | San Diego, California)View the full events calendar

Episode metadata supplied by the publisher feed · Published May 10, 2021

Embed this episode

Attribution link and audio player

NOW PLAYING

A Critical Platform

0:00 16:24

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of New Matter: Inside the Minds of SLAS Scientists?

This episode is 16 minutes long.

When was this New Matter: Inside the Minds of SLAS Scientists episode published?

This episode was published on May 10, 2021.

Can I download this New Matter: Inside the Minds of SLAS Scientists episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!